Envista (NYSE:NVST) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Envista (NYSE:NVST) had its price objective increased by Robert W. Baird from $17.00 to $22.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 5.06% from the company’s previous close.

NVST has been the topic of a number of other reports. Needham & Company LLC restated a “hold” rating on shares of Envista in a research note on Thursday, August 8th. Evercore ISI boosted their target price on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Stifel Nicolaus increased their price target on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Leerink Partners upgraded Envista from an “underperform” rating to a “market perform” rating and lifted their target price for the stock from $16.00 to $23.00 in a research report on Thursday. Finally, Bank of America lowered their price target on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $20.71.

Envista Stock Performance

Shares of NVST opened at $20.94 on Thursday. Envista has a 1 year low of $15.15 and a 1 year high of $25.64. The stock has a market capitalization of $3.60 billion, a PE ratio of -2.69 and a beta of 1.32. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.90 and a current ratio of 2.22. The stock has a 50-day simple moving average of $18.64 and a 200-day simple moving average of $18.08.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. Envista had a negative net margin of 53.42% and a positive return on equity of 3.59%. The company had revenue of $601.00 million during the quarter, compared to the consensus estimate of $590.34 million. During the same quarter in the previous year, the firm earned $0.43 earnings per share. The firm’s quarterly revenue was down 4.8% on a year-over-year basis. On average, analysts predict that Envista will post 0.69 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CFO Eric D. Hammes bought 24,532 shares of Envista stock in a transaction on Monday, August 12th. The shares were bought at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the acquisition, the chief financial officer now owns 24,532 shares in the company, valued at approximately $400,607.56. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Envista

Several hedge funds have recently made changes to their positions in the business. Ariel Investments LLC lifted its position in Envista by 11.0% during the second quarter. Ariel Investments LLC now owns 9,871,152 shares of the company’s stock worth $164,157,000 after buying an additional 978,952 shares during the period. Nuance Investments LLC lifted its holdings in shares of Envista by 47.2% during the 2nd quarter. Nuance Investments LLC now owns 7,038,313 shares of the company’s stock worth $117,048,000 after acquiring an additional 2,256,993 shares during the period. American Century Companies Inc. boosted its position in shares of Envista by 15.4% in the second quarter. American Century Companies Inc. now owns 6,726,651 shares of the company’s stock worth $111,864,000 after acquiring an additional 897,141 shares during the last quarter. Jupiter Asset Management Ltd. purchased a new stake in Envista in the second quarter valued at approximately $69,534,000. Finally, Van Lanschot Kempen Investment Management N.V. grew its holdings in Envista by 32.9% in the second quarter. Van Lanschot Kempen Investment Management N.V. now owns 2,936,916 shares of the company’s stock valued at $48,841,000 after purchasing an additional 727,406 shares during the period.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.